PharVision Advisers’s Acco Brands ACCO Stock Holding History

PharVision Advisers’s Portfolio ACCO Stock Details ACCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-83,379	Closed	-$438K	–	262
2024 Q4	$438K	Buy	+83,379	New	+$463K	0.37%	63

Other funds holding ACCO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

PharVision Advisers's ACCO Position: Q1 2025 in Review

PharVision Advisers sold out of Acco Brands (ACCO) in Q1 2025, closing a stake of 83,379 shares — an estimated $438K sold.

PharVision Advisers first reported a position in ACCO in Q4 2024 and held it in 1 quarter. The position peaked at $438K in Q4 2024. 222 funds tracked by Wall St. Rank hold ACCO as of Q1 2025.

PharVision Advisers reported no remaining Acco Brands position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 83,379 Acco Brands shares in Q1 2025, an estimated $438K.
PharVision Advisers first reported a position in Acco Brands in Q4 2024 and held it in 1 quarter.
PharVision Advisers's Acco Brands position peaked at $438K in Q4 2024.
222 funds tracked by Wall St. Rank held Acco Brands as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.